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Persistent lipid abnormalities in statin-treated patients with coronary artery
disease in China: part of the Dyslipidemia International Study
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School of Medicine, Shanghai, China
Objectives: To evaluate the prevalence of persistent lipid abnormalities and statin use
in Chinese patients with coronary artery disease.
Methods: This cross-sectional observational study consecutively enrolled 9420 out-
patients with coronary artery disease in China. ESC/EAS Guidelines for the man-
agement of dyslipidemia and Chinese guidelines on prevention and treatment of
dyslipidemia in adults were used to compare the control rate of low density lipoprotein
cholesterol, high density lipoprotein cholesterol and triglyceride.
Results: Among the 9420 participants, 33.6% was diagnosed as diabetes mellitus.
The percentage of patients with not-at-goal LDL cholesterol was signiﬁcantly lower in
patients with diabetes than those without diabetes (72.7% vs 73.2%, P<0.001). The
corresponding values for HDL-C and TG were 42.9% vs 34.2% (P<0.001) and 40.6%
vs 35.2% (P<0.001), respectively. Only about 10% patients had optimal LDL-C, HDL-
C and TG. Compared with patients without DM, patients with DM were more likely to
have mixed dyslipidemia. Atorvastatin (47.0%) and simvastatin (34.4%) were the two
most frequently used statin and the average statin dosage was 29.09 mg/d (simvastatin
equivalent). Drug combination with statin to modulate lipid was only 3%.
Conclusions: Although international guideline highly recommends intensive lipid
modiﬁcation in patients with coronary artery disease, persistent dyslipidemia was still
prevailing in China, even with statin treatment.
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Objectives: Familial hypercholesterolemia (FH) is a severe autosomal codominant
disorder that is characterized by an elevated concentration of low-density lipoprotein
cholesterol (LDL-C) and a high prevalence of premature coronary heart disease. We
report clinical cardiovascular data from one case of homozygous FH in China after a
seven-year study.
Methods: We obtained 50 FH patients with homozygous phenotypes who were
admitted to Anzhen Hospital between 2005 and 2007 and selected one patient who
was diagnosed with severe hyperlipidemia with early symptoms of cardiovascular
disease. After diagnosis of FH, we performed exon capture screening methods by
using a gene capture chip to genetic analysis and given cholesterol-lowering drugs to
treat the patient. Follow-up clinical data were collected over seven years.
Results: Genetic analysis conﬁrmed the diagnosis of compound heterozygous FH.
The patient had mutations in exon 2 Q12X, exon 6 N296T, and exon 6 892delA
which may cause severe loss of LDLR function, including endocytosis and degra-
dation in the LDL-R gene. Although the patient’s TC and LDL-C concentrations were
reduced by 28% and 6%, respectively, with a combination of cholesterol-lowering
drugs (10mg atorvastatin, 5mg ezetimibe plus 0.5mg probucol per day), both levels
remained higher than their target values. Clinical imaging data collected over seven
years showed that the left chamber of the patient’s heart was persistently dilated
and with mitral insufﬁciency (from mild to severe between 2007 and 2013),
myocardial ischemia due to multiple coronary artery stenoses, and multivessel plaque
formation.
Conclusions: Based on prevalences between 1/500 and 1/200, between 14 and 34
million individuals worldwide have FH. In China, there are approximately 2.6 million
potential FH patients. However, FH patients are underdiagnosed and undertreated in
China because both doctors and patients lack knowledge of FH. From our case report,
we can found the atherosclerosis has progress quickly in this HoFH child even if the
cholesterol-lowering drugs were given. We can image that the Chinese FH population
will have poor outcomes if we continue overlook this population, and this will also
potentially increasing costs for the country. Therefore, we hope our report will
encourage the government to devote more attention to this disease.
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University of Medical Sciences, IranJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/EObjectives: Based on burden of disease study in Iran, cardiovascular disease is the most
important causeof death anddisability andproper nutrition in early life is one of important
determinant of prolonged health. This studywas conducted to investigate the relationship
of infant feeding variables with cardiovascular ﬁtness in 7 to 8 years old children.
Methods: In a historical cohort study, 246 children age 7 to 8 years in both sexes were
selected. Children have no history of cardiovascular, renal or liver diseases. According
to the health ﬁle, nutrition of children in childhood determined and categorized into
three groups; children who breastfed more than 6 month, children who breastfed less
than 6 month and children which was formula fed and did not breastfeeding. Car-
diovascular ﬁtness determined with a treadmill ergometry. Regression analysis in
single and a 2-level linear regression models was used for examining the independent
relationships of infant-feeding variables, and cardiovascular ﬁtness.
Results: Breastfeeding more than 6 month have a signiﬁcant relation with cardiovas-
cular ﬁtness (p< 0.001). This relation was signiﬁcant also with control of confounders
(birth weight, children BMI, mother BMI, Physical activity, diet and fat mass).
Conclusions: Results of this study show that breastfeeding increase cardiovascular
ﬁtness in children. Cardiovascular ﬁtness and food pattern in childhood is modiﬁable
and attention to breastfeeding is important in children.
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Objectives: Metabolic syndrome as a group of cardiovascular risk factors including
central obesity, dyslipidemia, hypertension and insulin resistance and an important
threat to human health is correlated with obesity. This study was done to determine the
prevalence of metabolic syndrome in “healthy heart house” of Shiraz University of
Medical Sciences.
Methods: 350 patients from those referring to “healthy heart house” of Shiraz Uni-
versity of Medical Sciences were recruited. Those who were 20-65 years old were
included and those with secondary obesity as the result of drugs, genetic or endocrine
disorders were excluded. Weight and height were measured for calculating body
mass index. Waist circumference was also recorded. Blood pressure was measured
and for laboratory measurements, blood samples for participants were taken after an
overnight fasting. Plasma glucose, serum HDL-c and triglyceride were analyzed.
Presence of metabolic syndrome was determined using ATPIII criteria. SPSS 15 was
used for analyzing the data. Results were reported as mean  SD and percentage for
prevalence.
Results: According to the criteria, 37% of the participants had metabolic syndrome.
Most of the afﬂicted participants were obese and overweight. Waist circumference
was high in 57 percent of the participants. High serum triglyceride, low HDL-C and
hypertension were seen in 54.4%, 0.3% and 37.5% of the participants, respectively.
Conclusions: A high prevalence of metabolic syndrome seen in the study population
may be correlated with abdominal obesity. Yet, abdominal obesity can affect com-
ponents of metabolic syndrome such as hypertension and fasting glucose.Metabolic Syndromes
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